• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Olfactory, Gustatory Dysfunction Decline in Years Following COVID-19

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 15, 2023.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Nov. 15, 2023 -- The prevalence of olfactory dysfunction (OD) and gustatory dysfunction (GD) declines in the three years after COVID-19 infection, according to a research letter published online Nov. 9 in JAMA Otolaryngology-Head & Neck Surgery.

Paolo Boscolo-Rizzo, M.D., from the University of Trieste in Italy, and colleagues estimated the three-year prevalence of measured OD and GD associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. One-hundred individuals who tested positive for SARS-CoV-2 were matched with 100 controls recruited from hospital staff who tested negative for SARS-CoV-2. Eighty-eight cases completed all follow-up assessments.

The researchers found that during the acute phase of COVID-19 and at one-, two-, and three-year follow-up, the prevalence of self-reported smell or taste dysfunction was 64.8, 31.8, 20.5, and 15.9 percent, respectively, among cases. The prevalence of OD decreased during follow-up, with frequency of 40.9, 27.3, and 13.6 percent of one-, two-, and three-year evaluations, respectively. Cases were more likely to have OD than controls at two years after infection (27.3 versus 10.2 percent); however, at three years after COVID-19, no significant excess of OD was identified (13.6 and 10.2 percent, respectively). At one-, two-, and three-year evaluation, the prevalence of GD was 26.1, 13.6, and 11.4 percent, respectively; at two and three years after COVID-19, there were no differences in GD observed between cases and controls.

"Patients with post-COVID-19 condition exhibiting chemosensory alterations should be reassured that a recovery of olfaction appears to continue over three years after initial infection," the authors write.

One author disclosed ties to the biopharmaceutical, medical device, and nutrition industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.